CoreMap
PrivateLast Round
Series C
Jul 29, 2026
Est. Valuation
$180.05M
Total Funding Raised
$70.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CoreMap operates in Healthcare & Life Sciences and is based in Burlington, Massachusetts. Its latest recorded funding round was a Series C round in July 2026.
CoreMap is a medical device company that develops a diagnostic technology platform to identify the drivers of complex cardiac arrhythmias, such as atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoreMap Comparables
Compare CoreMap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnChannel Medical | 86% | |
| Cortex | 86% | |
| Volta Medical | 83% |
For institutional investors. Book with your work email.
CoreMap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 29, 2026 | ||||
| Early Stage VC | Jun 18, 2026 | ||||
| Early Funding | Jul 24, 2024 | ||||
| Series B | Feb 9, 2022 | ||||
| Series A Extension | Feb 9, 2022 | ||||
Series A | Sep 17, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CoreMap Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| America's Seed Fund | Grant |
| UVM Ventures | Series A |
| National Science Foundation | Grant |
| Qure Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 16, 2.3x the trailing average.
- Jul 29, 2026
$37M round led by Medtronic
For institutional investors. Book with your work email.
CoreMap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CoreMap's valuation, stock price, and market status.
Is CoreMap a public or private company?
CoreMap is a private company.
What is the current stock price of CoreMap?
CoreMap is a private company, so its shares have no public market price. Caplight tracks CoreMap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CoreMap worth (valuation)?
CoreMap's valuation is estimated at $180.1M based on funding round data.
Can I buy CoreMap stock?
CoreMap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CoreMap's last funding round?
CoreMap's most recent funding round was Series C on July 29, 2026.
Who are the main investors in CoreMap?
Key investors in CoreMap include Qure Ventures.
Will CoreMap IPO soon?
No public IPO plans have been announced for CoreMap.
How can I track CoreMap secondary market activity?
Caplight tracks bids, offers, and trades in CoreMap's shares on secondary markets.